View Financial HealthGem Aromatics 배당 및 자사주 매입배당 기준 점검 0/6Gem Aromatics 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-20.2%자사주 매입 수익률총 주주 수익률-20.2%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹145, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 20x in the Chemicals industry in India.New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹7.92b market cap, or US$86.4m).공시 • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).공시 • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).공시 • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025Board Change • Aug 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 544491 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 544491 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Gem Aromatics 배당 수익률 vs 시장544491의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (544491)n/a시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Chemicals)0.7%분석가 예측 (544491) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 544491 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 544491 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 544491 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 544491 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 21:40종가2026/05/22 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Gem Aromatics Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹145, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 20x in the Chemicals industry in India.
New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.
Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).
New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹7.92b market cap, or US$86.4m).
공시 • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.
New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).
Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).
공시 • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).
공시 • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025
Board Change • Aug 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.